- Neu
Cooper / Patel / Alexander Behavioral Impact of Cannabinoids
Erscheinungsjahr 2025
ISBN: 978-3-032-09133-8
Verlag: Springer International Publishing
Format: PDF
Kopierschutz: 1 - PDF Watermark
E-Book, Englisch, 455 Seiten
Reihe: Biomedical and Life Sciences (R0)
ISBN: 978-3-032-09133-8
Verlag: Springer International Publishing
Format: PDF
Kopierschutz: 1 - PDF Watermark
Despite millennia of proximity to, and consumption of products from, the plant, we have an incomplete understanding of its behavioural impact. This volume presents current research summaries in three sections, focussing on contextualisation of the work at molecular and cellular levels, and behavioural paradigms for investigating and cannabinoid preparations in non-human animals and humans. The contributors are leaders in their respective fields and internationally recognisable.
The book contents are unique in the progression that it encompasses the molecular understanding of cannabinoids through animal models of behaviour into humans. It reflects a resurgence in attempts to understand the potential therapeutic benefits of and cannabinoid preparations. This is evidenced by the increasing number of countries/states where -based products for medicinal use have been approved, as well as some notable locations where non-medicinal consumption of preparations has been legalised.
Zielgruppe
Research
Autoren/Hrsg.
Weitere Infos & Material
Preface.- Canonical Cannabinoid Receptors.- The pharmacological profile of plant-derived cannabinoids in vitro.- Chemical Probes for Exploiting the Endocannabinoid System.- Genetic Tools in Rodents to Study Cannabinoid Functions.- Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models.- Delta-9-tetrahydrocannabinol and Cannabidiol for Pain: Preclinical and Clinical Models.- Neurodegeneration and ageing.- Cannabinoid-based pharmacology for the management of drug relapse.- The role of cannabinoids and the endocannabinoid system in the treatment and regulation of nausea and vomiting.- The use of cannabis-based medicine in selected neurological disorders.
